92%Confidence
0Views
FDASource
2026-04-14Date
Summary
Sterility concerns extend to K.C. Pharmaceuticals' tetrahydrozoline eye drops, affecting both Perrigo and Walgreens private label products. This pattern suggests facility-wide contamination issues that could lead to FDA enforcement actions.
Actionable: Suspend sales of all K.C. Pharmaceuticals manufactured eye drops and implement enhanced quality checks for similar products.
AI Confidence: 92%
Data Points
firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productSterile Eye Drops ORIGINAL FORMULA (tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15mL) bottles; a) Good Sense Sterile Eye Drops, Distributed By: Perrigo Di
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now